Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $4.54B. Across the group, the median move over the past trading day is −1.58%. Price change over the past year runs from −12.0% to +238.2% across the middle 80 percent of the group, with a median of +76.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% |
| 0I3Q.L | Corcept Therapeutics Incorporated | $4.54B | Mid cap | +75.99% |
| HCM.L | HUTCHMED (China) Limited | $2.12B | Mid cap | −21.24% |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.